Print

Print


                        Parkinson's Disease Study

The University of Vermont College of Medicine Fletcher Allen Health Care -
Clinical Research Center in Burlington, Vermont is calling for participants
in a study on:

"The effects of acute and subchronic nicotine on attentional
functioning in Alzheimer's and Parkinson' Disease."

This study will test whether varying dosages of intravenous nicotine,
followed by nicotine administered by skin patch for two weeks, can improve
attentional learning and motor impairmants in Alzheimer's and Parkinson's
disease patients. This short-term study aims to develop better treatments
for patients with these disease.

Principal Investigator: Paul Newhouse, M.D.

Interested Parties should contact:
Christina Conrath, MSW (802)656-4560

NOTE:
Participants of the study who live a long distance from Burlington, Vermont
will be provided lodging during the impatient phase of the study at the
Clinical Research Center.